ArticleThrombosis journal2024

Lipoprotein apheresis: an established therapeutic modality for homozygous familial hypercholesterolemia patients refractory to PCSK9 inhibitors: a case report and literature review.

Mingjing Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.